Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

Sirona Biochem Announces Successful Synthesis of Anti-Inflammatory Compound for Bloom Burton & Co. Joint Venture

Marketwired July 31, 2014

Sirona Arranges Convertible Loans

Marketwired July 29, 2014

Sirona Biochem Announces Successful Completion of Two First Line Studies by Wanbang Biopharmaceuticals

Marketwired July 23, 2014

Sirona Announces Shares for Services Agreement

Marketwired July 22, 2014

Sirona Biochem Corporation - CEO Letter to Shareholders

Marketwired July 21, 2014

Sirona Announces Resignation of Neil Belenkie

Marketwired June 23, 2014

Sirona Biochem's Subsidiary, TFChem, Selected for UBISTART Tour 2014

Marketwired June 11, 2014

Sirona Announces Results of Shareholder Meeting

Marketwired June 10, 2014

Sirona Biochem Announces Wanbang Biopharmaceutical's Launch of Pre-Clinical Validation

Marketwired June 3, 2014

Microcap Report: Theralase Tech. (V.TLT), Sirona Biochem (V.SBM), Xmet (V.XME) active

Stockhouse Editorial May 29, 2014

Sirona Biochem (V.SBM) pops 5% on expanding skin lightening license with Valeant Pharmaceuticals

Stockhouse Editorial May 29, 2014

Sirona Biochem Expands Exclusive Skin Lightening License With Valeant Pharmaceuticals to Include AMBI and Kinerase

Marketwired May 29, 2014

Sirona's Science Boosts Anti-Aging Technology

GlobeNewswire May 26, 2014

Sirona Biochem's Anti-Aging Glycoprotein Successfully Extends Cell Life in Serum Deprivation Study

Marketwired May 20, 2014

Sirona Grant Stock Options

Marketwired April 25, 2014

Sirona Biochem Announces Collaboration With Magellan BioScience

Marketwired April 23, 2014

Sirona Engages Torrey Hills Capital

Marketwired April 17, 2014

Sirona Engages Torrey Hills Capital

Marketwired April 17, 2014

Sirona Biochem Announces Open Webinar for Q&A

Marketwired April 3, 2014

Sirona Biochem Announces Open Webinar for Q&A

Marketwired April 3, 2014